Compugen (CGEN)

Compugen Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next >>

Date	Time	Source	Headline	Symbol	Company
02/03/2015	12:09	Business Wire	Compugen to Present at Two Oncology Conferences in March	NASDAQ:CGEN	Compugen Ltd
27/02/2015	21:08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
23/02/2015	12:04	Business Wire	Compugen Expands and Strengthens Business Development Team	NASDAQ:CGEN	Compugen Ltd
10/02/2015	12:10	Business Wire	Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results	NASDAQ:CGEN	Compugen Ltd
10/02/2015	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
09/02/2015	12:14	Business Wire	Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target	NASDAQ:CGEN	Compugen Ltd
03/02/2015	12:09	Business Wire	Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST	NASDAQ:CGEN	Compugen Ltd
02/02/2015	12:39	Business Wire	Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month	NASDAQ:CGEN	Compugen Ltd
05/01/2015	12:14	Business Wire	Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets	NASDAQ:CGEN	Compugen Ltd
18/12/2014	12:02	Business Wire	Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University	NASDAQ:CGEN	Compugen Ltd
18/12/2014	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
03/12/2014	12:01	Business Wire	Compugen to Present at Oppenheimer 25th Annual Healthcare Conference	NASDAQ:CGEN	Compugen Ltd
02/12/2014	12:07	Business Wire	Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints	NASDAQ:CGEN	Compugen Ltd
12/11/2014	12:01	Business Wire	Compugen to Present at Jefferies 2014 Global Healthcare Conference in London	NASDAQ:CGEN	Compugen Ltd
29/10/2014	11:13	Business Wire	Compugen Ltd. Reports Third Quarter 2014 Financial Results	NASDAQ:CGEN	Compugen Ltd
29/10/2014	11:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
28/10/2014	11:02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
27/10/2014	11:01	Business Wire	Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate	NASDAQ:CGEN	Compugen Ltd
22/10/2014	12:11	Business Wire	Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
14/10/2014	19:02	Business Wire	Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer	NASDAQ:CGEN	Compugen Ltd
14/10/2014	18:49	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
06/10/2014	12:08	Business Wire	Compugen Immune Checkpoint Results Being Presented at Three Scientific Conferences	NASDAQ:CGEN	Compugen Ltd
01/10/2014	12:01	Business Wire	Compugen Discloses New Results for Novel Target Candidate for Cancer Immunotherapy	NASDAQ:CGEN	Compugen Ltd
29/09/2014	12:04	Business Wire	Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction	NASDAQ:CGEN	Compugen Ltd
05/09/2014	11:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CGEN	Compugen Ltd
04/09/2014	21:46	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:CGEN	Compugen Ltd
26/08/2014	21:06	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:CGEN	Compugen Ltd
26/08/2014	21:02	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
25/08/2014	12:09	Business Wire	Compugen Appoints Mr. Ari Krashin as Chief Financial Officer	NASDAQ:CGEN	Compugen Ltd
25/08/2014	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd